This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Kun Cheng, PhD
Curators' Distinguished Professor at University of Missouri-Kansas City


Dr. Kun Cheng is a Curators’ Distinguished Professor at the University of Missouri-Kansas City (UMKC) School of Pharmacy. Dr. Cheng has a diverse range of research experiences in phage display, peptide drug, drug delivery, nanotechnology, and cancer immunotherapy. His research focuses on the development of novel therapeutics for breast cancer, prostate cancer, pancreatic cancer, and liver fibrosis. One of his major research interests is to use phage display to discover peptides that can be used as therapeutic agents or targeting ligands for drug delivery and tumor diagnosis. He was recently inducted as an AAPS Fellow in 2020 and an American Institute for Medical and Biological Engineering (AIMBE) Fellow in 2021.

Agenda Sessions

  • Discovery of Small anti-PD-L1 Cyclic Peptides for Cancer Immunotherapy